The three main conclusions of this study are i) that the transmembrane phosphatase PTPRK, whose gene is found in prominent cancer-related fusion events with the ZNRF3 negative regulator RSPO3, is itself a positive regulator of ZNRF3. The gene discussed is ZNRF3; the disease is cancer.